| Jonathan is vice president and head of Global Clinical Sciences and Operations at UCB in Raleigh, NC. Jonathan joined UCB in April 2014 from Bristol-Myers Squibb, Princeton, NJ where he was vice president and head of Global Development Operations. In that role he led an organization of more than 1400 colleagues across 19 sites that was responsible for the global execution of clinical trials. He also led the integration of the $2.4 Billion Medarex acquisition in 2009. Jonathan is currently chair of the TransCelerate BioPharma, Inc. Operations Committee, which is responsible for the oversight and management of all TransCelerate workstreams and an ad hoc member of the TransCelerate Board of Directors. He is also a member of the CDSIC board of directors. |